Oncolytics Biotech (ONC.TO) Buy, Sell or Hold

Oncolytics Biotech (ONC.TO)

1.42

+0.03 (2.16%)

as of Aug 22, 2025, 8:00:00 pm Market Open.

16 watching

DON'T BUY

The technicals do not look good at all – with a decline lasting over the past two months. He would not touch this one at all. A 50 day moving average would be a buy signal if it can trade back above it.

Wealthica Track your Stocks in your Watch List

COMMENT

Phase 2 cancer company with some pretty decent results. They are a long way away from where they want to be. Product has huge potential.

WEAK BUY

Not aware of any upcoming short term catalysts. Continuing with their trials. Never had bad results. Very volatile and still early stage.

WAIT

Has a pretty high beta, so the stock goes up and down like a yo-yo. Likes with the company is doing. At some point, a major pharmaceutical company will get interested in their technology. Would like to see more trials and results.

DON'T BUY

If they can find the right deals and get through the clinical trials, the upside would be phenomenal. Very volatile right now.

WEAK BUY

A wild stock. Created a virus that could reduce cancer dramatically. Long term potential could be good. Trials have only been small ones. Risky.

WEAK BUY

Biotechs have had good moves. Has a ways to go before their drug is on the market. Speculative in the short term.

WEAK BUY

Interesting technology. Trials are turning out well, but too small a sampling at this time. Speculative.

Wealthica Track your Stocks in your Watch List

Showing 1 to 8 of 8 entries

Oncolytics Biotech (ONC.TO) Frequently Asked Questions

What is Oncolytics Biotech stock symbol?

Oncolytics Biotech is a Canadian stock, trading under the symbol ONC.TO (previously ONC-T on Stockchase) on the Toronto Stock Exchange (ONC-CT). It is usually referred to as TSX:ONC or ONC.TO

Is Oncolytics Biotech a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on ONC.TO (previously ONC-T on Stockchase) on Stockchase. Read the latest expert commentary for Oncolytics Biotech.

Is Oncolytics Biotech a good investment or a top pick?

Oncolytics Biotech was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Oncolytics Biotech.

Why is Oncolytics Biotech stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Oncolytics Biotech.

Is Oncolytics Biotech worth watching?

Oncolytics Biotech is followed by 16 investors on Stockchase and is a trending stock that is worth watching.

What is Oncolytics Biotech stock price?

On 2025-08-22, Oncolytics Biotech (ONC.TO) stock closed at a price of $1.42.

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Oncolytics Biotech (ONC.TO)

Oncolytics Biotech(ONC.TO)

Oncolytics Biotech(ONC.TO)

Oncolytics Biotech(ONC.TO)

Oncolytics Biotech(ONC.TO)

Oncolytics Biotech(ONC.TO)

Oncolytics Biotech(ONC.TO)

Oncolytics Biotech(ONC.TO)

Oncolytics Biotech(ONC.TO)